BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15540682)

  • 1. Raising the bar for the ethical integrity of clinical trials.
    Warnock GL
    Can J Surg; 2004 Oct; 47(5):327-8. PubMed ID: 15540682
    [No Abstract]   [Full Text] [Related]  

  • 2. Can underpowered clinical trials be justified?
    Rosoff PM
    IRB; 2004; 26(3):16-9. PubMed ID: 15281196
    [No Abstract]   [Full Text] [Related]  

  • 3. NCI's clinical trial system: efficiencies grow, debate goes on.
    Nicholas J
    J Natl Cancer Inst; 2010 Dec; 102(23):1750-1, 1755. PubMed ID: 21088280
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple competing interests surround ethical review of clinical trials.
    Henderson D
    Intern Med J; 2005 Nov; 35(11):686-7. PubMed ID: 16248869
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking cessation in clinical trials and public health studies: a research ethical imperative.
    Kanarek N; Kanarek MS
    Ann Epidemiol; 2007 Dec; 17(12):983-7. PubMed ID: 17855118
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees.
    Dal-Ré R; Luque I; Torres R; Lahuerta J
    Pharmacogenomics J; 2009 Apr; 9(2):86-9. PubMed ID: 19079365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource and needs of research ethics committees in Africa: preparations for HIV vaccine trials.
    Milford C; Wassenaar D; Slack C
    IRB; 2006; 28(2):1-9. PubMed ID: 16770882
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethics of private panels comes under scrutiny.
    Wadman M
    Nature; 1997 May; 387(6632):445. PubMed ID: 9168099
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioethics activities in India.
    Kumar NK
    East Mediterr Health J; 2006; 12 Suppl 1():S56-65. PubMed ID: 17037690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing trials of traditional medicines and other challenges faced by ethics committees.
    Cash R
    Indian J Med Ethics; 2008; 5(4):185-7. PubMed ID: 18988381
    [No Abstract]   [Full Text] [Related]  

  • 11. Institutional review boards should require clinical trial registration.
    Levin LA; Palmer JG
    Arch Intern Med; 2007 Aug 13-27; 167(15):1576-80. PubMed ID: 17698679
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
    Mann H; Shamoo AE
    Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: publishing cancer clinical trial results: a scientific and ethical imperative.
    Doroshow JH
    Oncologist; 2008 Sep; 13(9):930-2. PubMed ID: 18794215
    [No Abstract]   [Full Text] [Related]  

  • 16. Federal drug agency gets flack about human subjects protections in clinical trials.
    Beckman M
    J Natl Cancer Inst; 2008 Jan; 100(2):90-1. PubMed ID: 18182612
    [No Abstract]   [Full Text] [Related]  

  • 17. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In loco parentis. Minimal risk as an ethical threshold for research upon children.
    Freedman B; Fuks A; Weijer C
    Hastings Cent Rep; 1993; 23(2):13-9. PubMed ID: 8463083
    [No Abstract]   [Full Text] [Related]  

  • 19. Reforming the oversight of multi-site clinical research: a review of two possible solutions.
    Nowak KS; Bankert EA; Nelson RM
    Account Res; 2006; 13(1):11-24. PubMed ID: 16770857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Independent Ethics Committees for clinical research in Argentina. An evaluation and a system to guarantee their independence].
    Roldán EJ
    Medicina (B Aires); 2009; 69(1 Pt 2):205-6; author reply 206. PubMed ID: 19582958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.